Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties. Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties. Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
140
The follow-up time for each patient is 12 months with evaluation of the main objective by a standardized questionnaire: The Functional Assessment of Cancer Therapy-Anaemia (FACT-An) Scale at 6 months. Throughout the study, patients included will receive conventional haematological care and the interventional arm will benefit in addition to a monthly consultation by a palliative care team.
Centre Hospitalier Métropole Savoie
Chambéry, France
NOT_YET_RECRUITINGChu Clermont-Ferrand
Clermont-Ferrand, France
RECRUITINGChu Limoges
Limoges, France
RECRUITINGCentre Léon Bérard
Lyon, France
NOT_YET_RECRUITINGInstitut de Cancérologie de la Loire
Saint-Priest-en-Jarez, France
RECRUITINGCH Jacques Lacarin
Vichy, France
NOT_YET_RECRUITINGQuality of life evaluation: standardized questionnaire
Evaluation of quality of life by a standardized questionnaire : Functional Assessment of Cancer Therapy-Anemia (FACT-An). The higher is the score the better is the quality of life. FACT-An is composed by five subscales: Physical Well-Being \[score range 0-28\], Social/Family Well-Being \[score range 0-28\], Emotional Well-Being \[score range 0-24\], and Functional Well-Being \[score range 0-28\] and specific questions concerning anemia \[score range 0-80\]. The score at each items is summed. The sum is multiplied par the number of items in the subscale and then divided by the number of items answered. This produces the subscale score. The subscale scores are added to derive total score \[score range 0-188\].
Time frame: at 6 months
Presence of discomfort symptoms
evaluated by Edmonton scale (depressive syndrome measured by the geriatric depression scale GDS)
Time frame: at Day 0, 3 months, 6 months, 9 months, 12 months
overall survival
Time frame: at day 1 : from the randomization until the date of death or until 1 year [study end].
Satisfaction of the care pathwaydesired by the patient
matching between patients desires writing in the medical file and the providing care
Time frame: at 12 months or death
cost-effectiveness analysis
The cost criteria selected will be all the direct medical costs inherent in care in both arms (costs of hospitalizations, consultations, treatments, medical devices).
Time frame: at 12 months or death
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.